CCT3-SYT2 Fusion FISH Probe
The CCT3-SYT2 Fusion FISH Probe is used to confirm a fusion of the CCT3 and SYT2 genes. The fusion of the CCT3 and SYT2 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CCT3-SYT2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CCT3-SYT2-20-AQAQ | 20 (40 μL) | 200 μL |
|
CCT3 Gene Summary
The protein encoded by this gene is a molecular chaperone that is a member of the chaperonin containing TCP1 complex (CCT), also known as the TCP1 ring complex (TRiC). This complex consists of two identical stacked rings, each containing eight different proteins. Unfolded polypeptides enter the central cavity of the complex and are folded in an ATP-dependent manner. The complex folds various proteins, including actin and tubulin. Alternate transcriptional splice variants have been characterized for this gene. In addition, a pseudogene of this gene has been found on chromosome 8. [provided by RefSeq, Aug 2010]
Gene Name: Chaperonin Containing TCP1 Subunit 3
Chromosome: CHR1: 156278751 -156308206
Locus: 1q22
SYT2 Gene Summary
This gene encodes a synaptic vesicle membrane protein. The encoded protein is thought to function as a calcium sensor in vesicular trafficking and exocytosis. Mutations in this gene are associated with myasthenic syndrome, presynaptic, congenital, with or without motor neuropathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2014]
Gene Name: Synaptotagmin 2
Chromosome: CHR1: 202559724 -202679551
Locus: 1q32.1
Gene Diseases
The CCT3 SYT2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|